Bloomberg：

China Drugmaker Plunges After Wanda Scion Doubts Covid Medicine Efficacy

Shares of a traditional Chinese medicine-maker plunged by the daily limit after the son of one of China’s richest men questioned the efficacy of its drug commonly used to treat mild cases of Covid-19 in China.

Shijiazhuang Yiling Pharmaceutical fell by 10% in Shenzhen on Monday after Wang Sicong —Wanda Group Chairman Wang Jianlin’s son — reposted a video late last week on Weibo that questioned whether the World Health Organization had ever recommended the firm’s drug as Covid-19 treatment.

生词短语：

scion

(尤指名门望族的)子弟

efficacy

功效

mild case

轻症

repost

再发送